Welcome and Introductions
Dwayne Howell, PhD, President and CEO of The Leukemia & Lymphoma Society, welcomes one and all to the symposium.
More Information . . .

Developments in the Treatment and Research of AML
Dr. Selina Luger, Director of the Leukemia Program of the University of Pennsylvania Medical Center in Philadelphia gives a cogent concise explanation of what leukemia is and how it arises. She talks about recent advances in leukemia treatment and new therapies on the horizon.
More Information . . .

Hope for the Future: Research into Treatments for AML
Dr. Frederick Appelbaum, Senior Vice President and Director of the Clinical Research Division of the Fred Hutchinson Cancer Research Center in Seattle, says that leukemia research over the past decade has set the stage for the many exciting therapies on the horizon for AML and other leukemias. He reviews several treatments being studied and optimized at his institution, including therapies that target the WT1 antigen and agents like Mylotarg that target the CD33 antigen.
More Information . . .

Living With Acute Myeloid Leukemia
Rachel Odo, Clinical Social Worker at the Memorial Sloan-Kettering Cancer Center in New York, discusses the feelings and emotions experienced by many cancer patients at various stages of their illness and offers ways for them to cope.
More Information . . .

Question and Answer Session
In a question-and-answer session, audience members ask about exposure to benzene and risk of AML, support groups, autologous bone-marrow transplants, selecting bone-marrow donors, MDR modulation, Mylotarg availability, AML complicated by MDS, living wills and health proxies, post-remission treatment, and interpreting statistics.
More Information . . .

A Survivor's Perspective
Mark-Alan Lillibridge, an AML survivor and volunteer for The Leukemia & Lymphoma Society, talks about his diagnosis and treatment, emphasizing the important role that humor and laughter played during his treatment and recovery.
More Information . . .

Closing Remarks
Dwayne Howell, President and CEO of The Leukemia & Lymphoma Society, offers closing remarks and thanks the speakers and the event's sponsors.
More Information . . .